dravet

experimental-therapy-for-dravet-syndrome-shows-remarkable-efficacy-and-safety-in-clinical-trials

Experimental Therapy for Dravet Syndrome Shows Remarkable Efficacy and Safety in Clinical Trials

Nila Kartika Wati July 18, 2026

An international clinical trial, spearheaded by leading institutions including University College London (UCL) and...

breakthrough-therapy-for-dravet-syndrome-shows-remarkable-efficacy-and-safety-offering-new-hope-for-children-with-severe-epilepsy

Breakthrough Therapy for Dravet Syndrome Shows Remarkable Efficacy and Safety, Offering New Hope for Children with Severe Epilepsy

Nila Kartika Wati July 11, 2026

An experimental gene-targeted therapy, zorevunersen, has demonstrated promising results in an international clinical trial,...

experimental-therapy-for-severe-childhood-epilepsy-shows-remarkable-safety-and-efficacy-offering-new-hope-for-dravet-syndrome-patients

Experimental Therapy for Severe Childhood Epilepsy Shows Remarkable Safety and Efficacy, Offering New Hope for Dravet Syndrome Patients.

Nila Kartika Wati May 24, 2026

Results from a groundbreaking international clinical trial, spearheaded by University College London (UCL) and...

pioneering-experimental-therapy-shows-high-efficacy-and-safety-in-reducing-seizures-for-children-with-severe-dravet-syndrome

Pioneering Experimental Therapy Shows High Efficacy and Safety in Reducing Seizures for Children with Severe Dravet Syndrome

Nila Kartika Wati April 2, 2026

An international clinical trial, spearheaded by researchers at UCL (University College London) and Great...

an-experimental-gene-targeted-therapy-for-dravet-syndrome-shows-remarkable-safety-and-efficacy-in-pioneering-clinical-trial

An Experimental Gene-Targeted Therapy for Dravet Syndrome Shows Remarkable Safety and Efficacy in Pioneering Clinical Trial

Nila Kartika Wati March 26, 2026

An investigational therapy, zorevunersen, designed to address the underlying genetic cause of Dravet syndrome,...